Home Featured

Featured

Random

Is Cannabis Psychedelic? Examining the Scientific Evidence

Bridging Worlds: Psychedelics, Community, and the Work of Our Time

MindMed Completes 1-for-15 Reverse Share Split

Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity

Vince Kadlubek – Meow Wolf & PORTAL

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Can Psilocybin and LSD Relieve Existential Suffering?

Silo Pharma Enters into Agreement with Contract Research Organization for Pharmacokinetic...

Psychedelic Bulletin #129: New Year, New Psychedelic Bills; WHO Dubs 5-MeO-DMT...

Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr....

Sunstone Therapies Announces Expansion of Innovative Dyad Study

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

CB Therapeutics granted a new patent that will help further provide...

Pα+ Psychedelic Patent Analysis: April 2024

12 3...327 Page 1 of 327

EDITOR PICKS

Timothy Leary Did Not Cause the Drug War

Before the Approvals Arrive: Norway, Germany, Switzerland, the UK and Estonia...

From Ecstasy Rising to Peaking: Jordan Kronick on 20 Years Covering...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.